• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Life-Sciences-UK.com
The British Life Sciences Web Portal

This is a free web portal for the life sciences in the UK and Ireland... » read more

• Rexgenero: Atelerix Consortium Gets £267k Innovate UK Grant (2019-08-21)
  Rexgenero, a regenerative medicine company pioneering the development of advanced cell-based therapies to treat chronic limb-threatening ischaemia (CLI), welcomes the news announced today by Atelerix that it has been awarded a grant of £267,000 from Innovate UK. ...
• AZ: Phase 3 of Imfinzi/Tremelimumab in NSCLC Misses Endpoint (2019-08-21)
  AstraZeneca today announced final overall survival (OS) results from the Phase III NEPTUNE trial, a randomised, open-label, multi-centre, global trial of Imfinzi (durvalumab) in combination with tremelimumab, an anti-CTLA4 antibody, vs. standard-of-care (SoC) plati...
• Nabriva: FDA Approves Xenleta (lefamulin) for CABP (2019-08-19)
  > First New IV and Oral Antibiotic with a Novel Mechanism of Action Approved in Nearly Two Decades Provides Critically Needed Treatment Option for Adult Patients with CABP > XENLETA Expected to be Available mid-September 2019 > Conference call and webcast t...
• Juvenescence Closes $100m Series B Round (2019-08-19)
  Juvenescence, a life sciences company utilising expert drug developers and artificial intelligence experts to create therapeutics and technologies to treat diseases of aging and to increase human longevity, is pleased to announce the successful closure of its $100 ...
• AskBio Acquires Synpromics Ltd. (2019-08-13)
  Synpromics to operate as a wholly owned subsidiary; the two companies bring together pioneering technology to increase efficacy of gene therapeutics AskBio, the world’s foremost clinical stage and gene therapy platform company, has acquired Synpromics, the lea...
• Startup AstonauTx Gets £6.5m from Dementia Disocvery Fund (2019-08-13)
  A new biotech company, AstronauTx Ltd, which builds on work from the Alzheimer’s Research UK UCL Drug Discovery Institute (DDI), has received an investment of £6.5 million from the government-launched Dementia Discovery Fund (DDF). The UCL DDI is a dedicated cen...
• Maya Martinez-Davis to Join GSK as President US Pharma (2019-08-12)
  GSK today announced that Jack Bailey, President US Pharmaceuticals has decided to step down from his role at the end of the year. Bailey will be succeeded by Maya Martinez-Davis, currently Regional President, Latin America Region at EMD Serono, the biopharmaceutica...
• Jazz Pharmaceuticals Acquires Cavion Inc. for up to $312.5m (2019-08-12)
  > Transaction Adds Worldwide Rights to CX-8998, a Modulator of T-type Calcium Channels, for the Potential Treatment of Essential Tremor > Strong Strategic Fit with a Differentiated Mechanism of Action in an Area of High Unmet Need and Limited Treatment Options ...
• Circassia Appoints Jonathan Emms as Chief Operating Officer (2019-08-12)
  – COO to join Board and SVP R&D to step down as Director reflecting Company’s commercial focus – Circassia Pharmaceuticals plc (“Circassia” or “the Company”; LSE: CIR), a specialty biopharmaceutical company focused on respiratory disease, today announces the a...
• MeiraGTx Prices up to $86.5m Public Offering at $23.5/Share (2019-08-08)
  MeiraGTx Holdings plc (Nasdaq:MGTX), a vertically integrated, clinical stage gene therapy company, today announced the pricing of an underwritten public offering of 3,200,000 of its ordinary shares at a public offering price of $23.50 per share. In addition, MeiraG...

Life-Sciences-UK.com is your doorway to the British and Irish life sciences!

[LSUK] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations


in the UK and Ireland.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSUK] is 100% Made in Germany!

Start here with the latest News!

Advertisement

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2019. Made in Germany.